Executive Summery
This report presents a detailed overview of the Carrier Screening Market, highlighting key insights into its market size, share, and growth during the forecast period, i.e., 2024-30. It explores emerging trends, competitive dynamics, and the core drivers reshaping the industry. Backed by solid data and expert analysis, the study offers segment-wise insights and reliable forecasts to guide strategic decisions. With comprehensive market analysis and forward-looking perspectives, this report serves as a practical tool for stakeholders navigating change. Whether you're an investor, policymaker, or business leader, this research helps you stay ahead in the fast-evolving Carrier Screening industry landscape.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/carrier-screening-market.html
Carrier Screening Market Statistics and Key Highlights
The Global Carrier Screening Market size was valued at around USD 2.09 billion in 2023 & is estimated to grow at a CAGR of around 20.7% during the forecast period, i.e., 2024–30.
- Carrier Screening market shows steady growth
- Market size expanding due to rising industry demand
- Competitive landscape driven by tech and innovation
- Detailed segment-wise and geography wise share analysis
- Forecast reveals strong trends shaping future outlook
Key Player- Emerging Carrier Screening Companies
- NATERA, INC.
- QUEST DIAGNOSTICS INCORPORATED
- FULGENT GENETICS
- INVITAE CORPORATION
- EUROFINS SCIENTIFIC
- OPKO HEALTH, INC.
- THERMO FISHER SCIENTIFIC INC.
- MYRIAD GENETICS, INC.
- ILLUMINA, INC.
- CENTOGENE N.V.
- DIASORIN S.P.A.
- OTOGENETICS
- GENETECH
- LABORATORY CORPORATION OF AMERICA HOLDINGS
Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/carrier-screening-market.html
Use your official business email to connect with our team and enjoy full access with priority support.
Key Driver:
Rising Prevalence of Genetic Disorders – The increasing occurrence and understanding of genetic disorders are major factors driving the growth & expansion of carrier screening services. Carrier screening is a crucial methodology for pinpointing individuals who possess one copy of a gene mutation linked to a particular genetic ailment. Approximately 10,000 distinct types of single-gene diseases, also known as monogenic diseases, exist, wherein mutations in a single gene cause the ailment. According to the World Health Organization Report, it has been estimated that 9 out of every 999 individuals are adversely impacted by these conditions. This suggests that about 85 million people are grappling with one of these diseases worldwide.
Carrier Screening Market Segmentation
By Product & Service
- Services- Market Size & Forecast 2019-2030, (USD Million)
- Products- Market Size & Forecast 2019-2030, (USD Million)
By Type
- Expanded Carrier Screening- Market Size & Forecast 2019-2030, (USD Million)
- Predesigned Panel Testing- Market Size & Forecast 2019-2030, (USD Million)
- Customized Panel Testing- Market Size & Forecast 2019-2030, (USD Million)
- Targeted Disease Carrier Screening- Market Size & Forecast 2019-2030, (USD Million)
The targeted disease carrier screening segment is set to hold a major share of the market throughout the forecast period in the carrier screening industry.
By Medical Condition
- Pulmonary Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Hematological Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Neurological Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
By Technology
- DNA Sequencing- Market Size & Forecast 2019-2030, (USD Million)
- PCR- Market Size & Forecast 2019-2030, (USD Million)
- DNA Microarrays- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
By End-User
- Hospitals & Medical Centers- Market Size & Forecast 2019-2030, (USD Million)
- Clinical Laboratories- Market Size & Forecast 2019-2030, (USD Million)
- Fertility Clinics- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
During the forecast period, North America is expected to dominate the Global Carrier Screening Market in terms of market size & volume.
Reasons to Buy This Report
- Gain comprehensive insights into current market trends and dynamics.
- Equip your business with data-driven strategies for informed decisions.
- Identify lucrative market opportunities and strategic growth areas.
- Analyze competitors to enhance your positioning in the market landscape.
- Understand geographical trends across diverse markets for better expansion strategies.
Looking for Global, Regional or country-specific reports on this market?
Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support - https://www.marknteladvisors.com/query/request-customization/carrier-screening-market.html
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us:
MarkNtel Advisors LLP
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
For Sales Enquiries: [email protected]